维普中文期刊产品整合服务
18篇 您的检索式:作者名="Tinker AV"
    题名 作者 年代 出处 被引量
1Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience 显示文摘Tinker AV Bhagat K Swenerton KD 2005Gynecol Oncol2005,98,:1
2Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG显示文摘Tinker AV Gebski V Fitzharris B 2007Gyneeol Oncol2007,104,3:1
3The role of PARP inhibitors in the treatment of ovarian carcinomas 显示文摘Tinker AV Gelmon K 2012Curr Pharm Des2012,18,25:1
4Intraepithelial T cells and prognosisin ovarian carcinoma:novel associations with stage,tumor type,and BRCA1loss显示文摘Clarke B Tinker AV Lee CH 2009Modern Pathol2009,22,3:1
5Carboplatin and paclitaxel for advanced and recurrent cervical carcino- ma: the British Columbia Cancer Agency experience 显示文摘Tinker AV Bhagat K Swenerton KD 2005Gynecol Oncol2005,98,1:1
6Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome显示文摘Tothill RW Tinker AV George J 2008Clin Cancer Res2008,14,16:1
7Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical out-come显示文摘Tothil RW Tinker AV George J 0,,16:1
8Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel - ANZGOG 02 -01 显示文摘Tinker AV Gebski V Fitzharris B 2007Gynecol Oncol2007,104,3:1
9Phase Ⅱ trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01显示文摘Tinker AV Gebski V Fitzharris B 2007Gynecol Oncol2007,104,3:1
10The challenges of gent expression microarrays for the study of human cancer 显示文摘Tinker AV Boussioutas A Bowtell DDL 2006Cancer Cell2006,9,:1
11Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome显示文摘Tothill RW Tinker AV George J 2008Clin Cancer Res2008,14,16:1
12Factors influencing the willingness of US women to vaccinate their daughters against the human papillomavirus to prevent cervical cancer 显示文摘LAI JY Tinker AV Cheung WY 2013Medical Oncology2013,30,2:1
13The challenges of gene expression microarrays for the study of human cancer显示文摘Tinker AV Boussioutas A Bowtell DD 2006Cancer Cell2006,9,5:1
14Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel-ANZGOG 02-01 显示文摘Tinker AV Gebski V Fitzharris B 2007Gynecol Oncol2007,104,3:1
15The role of PARP inhibitors in the treatmentof ovarian carcinomas 显示文摘Tinker AV’Gelmon K 2012Curr Pharm Des2012,18,25:1
16Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience显示文摘Tinker AV Bhagat K Swenerton KD 2005Gynecol Oncol2005,98,1:1
17Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience显示文摘Tinker AV Bhagat K Swenerton KD 2005Gynecol Oncol2005,98,1:1
18Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome显示文摘Tothill RW Tinker AV George J 2008Clin Cancer Res2008,14,16:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费